Geriatric pharmacotherapy updates

David R.P. Guay1,2
1Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA
2Division of Geriatrics, PartneringCare Senior Services, HealthPartners Inc., St. Paul, Minnesota, USA

Tài liệu tham khảo

Li, 2005, Meta-analysis: Pharmacologic treatment of obesity, Ann Intern Med, 142, 532, 10.7326/0003-4819-142-7-200504050-00012 Wells, 2005, A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism, Arch Intern Med, 165, 733, 10.1001/archinte.165.7.733 Derosa, 2005, Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome, Pharmacotherapy, 25, 637, 10.1592/phco.25.5.637.63587 Chen, 2005, Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial, Lancet, 366, 1607, 10.1016/S0140-6736(05)67660-X Chen, 2005, Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial, Lancet, 366, 1622, 10.1016/S0140-6736(05)67661-1 Lexau, 2005, Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine, JAMA, 294, 2043, 10.1001/jama.294.16.2043 Hill, 2002, The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion—correlation of in vivo and in vitro studies, Drug Metab Dispos, 30, 13, 10.1124/dmd.30.1.13 AHFS Drug Information 2005. Uricosuric agents—probenecid (40:40). Bethesda, Md: American Society of Health-System Pharmacists; 2601–2603. Demers, 2005, Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure, JAMA, 294, 1794, 10.1001/jama.294.14.1794 Pitzmaurice, 2005, Self management of oral anticoagulation: Randomised trial, BMJ, 331, 1057, 10.1136/bmj.38618.580903.AE White, 2005, Circulation, 112, 3391, 10.1161/CIRCULATIONAHA.105.551143 Keech, 2005, Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial, Lancet, 366, 1849, 10.1016/S0140-6736(05)67667-2 Liperoti, 2005, Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents, Arch Intern Med, 165, 2677, 10.1001/archinte.165.22.2677 Hensen, 2005, Outcomes in 45 patients with statin-associated myopathy, Arch Intern Med, 165, 2671, 10.1001/archinte.165.22.2671 ACC/AHA Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) Available at: http://www.acc.org/clinical/guidelines/stemi/Guideline1/index.pdf Milne, 2006, Meta-analysis: Protein and energy supplementation in older people, Ann Intern Med, 144, 37, 10.7326/0003-4819-144-1-200601030-00008 Dial, 2005, Use of gastric acid-suppressive agents and the risk of communityacquired Clostridium difficile-associated disease, JAMA, 294, 2895, 10.1001/jama.294.23.2989 Thurlimann, 2005, A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer, N Engl J Med, 353, 2747, 10.1056/NEJMoa052258